Lifecore Biomedical, Inc. (LFCR)
LFCR moved a median of +0.12% 30 minutes after news, and +0.20% by the close. How LFCR actually reacts to news — the realized, point-in-time move the market made, measured across 720 labeled events over the last three years with zero look-ahead.
LFCR’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 46% | 661 |
| 30-min | +0.12% | 52% | 718 |
| 60-min | -0.03% | 48% | 720 |
| to close | +0.20% | 54% | 717 |
| Middle 50% of LFCR reactions | -0.79% to +0.83% |
|---|---|
| Median reaction (30-min) | +0.12% |
| Measured reactions | 720 |
Half of all Lifecore Biomedical, Inc. news events land between -0.79% and +0.83% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when LFCR moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to LFCR's baseline. Nothing else.
Recent LFCR events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Lifecore Biomedical to Participate at Upcoming Industry Conferences | Press release | GlobeNewswire | +0.23% | +0.00% | |
| Are RXO, PTC, LFCR, WAFD Obtaining Fair Deals for their Shareholders? | Press release | PR Newswire | +0.00% | -0.92% | |
| Halper Sadeh LLC is Investigating Whether LFCR and SSTI are Obtaining Fair Deals for their Shareholders | Press release | GlobeNewswire | -0.15% | -0.61% | |
| Form 8-K LIFECORE BIOMEDICAL, For: Sep 24 | SEC filing · Form 8-K | SEC EDGAR | +0.61% | +0.46% | |
| Form 8-K LIFECORE BIOMEDICAL, For: Sep 27 | SEC filing · Form 8-K | SEC EDGAR | -0.31% | +0.00% | |
| Form DEFA14A LIFECORE BIOMEDICAL, | SEC filing · Form DEFA14A | SEC EDGAR | -0.31% | +0.00% | |
| LFCR Stock Alert: Halper Sadeh LLC is Investigating Whether Lifecore Biomedical, Inc. is Obtaining a Fair Price for its Shareholders | Press release | Business Wire | +0.00% | -0.76% | |
| Lifecore Biomedical to be Acquired by Webster Equity Partners | Press release | GlobeNewswire | -0.31% | +0.00% | |
| Lifecore Biomedical to Participate at CPHI Global Conference | Press release | GlobeNewswire | -1.15% | +1.15% | |
| Lifecore Biomedical Signs Agreement for Commercial Site Transfer Supporting Global Pharmaceutical Company | Press release | GlobeNewswire | +1.70% | +7.24% | |
| Lifecore Biomedical Reports Financial Results for the Second Quarter Ended June 30, 2026, and Provides Corporate Update | Press release | GlobeNewswire | +2.73% | +1.14% | |
| Lifecore Biomedical to Report Financial Results for the Second Quarter Ended June 30, 2026, on August 5, 2026 | Press release | GlobeNewswire | -0.69% | +0.69% | |
| Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | +6.44% | -0.40% | |
| Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company | Press release | GlobeNewswire | -0.28% | -3.68% | |
| Lifecore Biomedical Signs Agreement with New Biopharmaceutical Customer | Press release | GlobeNewswire | -1.03% | +11.91% | |
| Lifecore Biomedical to Participate in William Blair 46th Annual Growth Stock Conference | Press release | GlobeNewswire | +0.99% | +9.93% | |
| Lifecore Biomedical to Participate at CDMO Live Europe | Press release | GlobeNewswire | -0.44% | -0.44% | |
| Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update | Press release | GlobeNewswire | -0.40% | +0.20% | |
| Lifecore Biomedical to Report Financial Results for the First Quarter Ended March 31, 2026, on May 6, 2026 | Press release | GlobeNewswire | +1.42% | +2.63% | |
| Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | +1.35% | -5.02% | |
| Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit | Press release | GlobeNewswire | +1.78% | +0.47% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | +1.23% | +0.73% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out | Press release | ACCESS Newswire | +1.54% | +5.99% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | -0.53% | +1.86% | |
| Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | Press release | GlobeNewswire | -1.82% | -4.69% | |
| Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer | Press release | GlobeNewswire | +0.24% | -7.64% | |
| Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.24% | -8.08% | |
| Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company | Press release | GlobeNewswire | -1.31% | +0.25% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | -1.31% | +0.25% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Connect | Press release | ACCESS Newswire | +0.00% | +2.11% | |
| Lifecore Biomedical Reports Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, and Provides Corporate Update | Press release | GlobeNewswire | -3.44% | -31.80% | |
| Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | -3.44% | -31.80% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation | Press release | ACCESS Newswire | — | -1.12% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation | Press release | ACCESS Newswire | — | -3.63% | |
| Lifecore Biomedical to Participate in 6th Annual KeyBanc Capital Markets Healthcare Virtual Forum | Press release | GlobeNewswire | +0.73% | — | |
| Lifecore Biomedical to Report Financial Results for the Fourth Quarter and Transition Period Ended December 31, 2025, on March 16, 2026 | Press release | GlobeNewswire | -0.58% | +0.44% | |
| Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment | Press release | GlobeNewswire | +0.00% | +0.57% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Shareholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.95% | +2.27% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | +0.00% | +1.12% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out | Press release | ACCESS Newswire | +0.20% | +0.20% | |
| Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.00% | +2.53% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.00% | +1.13% | |
| Lifecore Biomedical to Participate at DCAT Week 2026 | Press release | GlobeNewswire | +1.55% | +0.99% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation | Press release | ACCESS Newswire | -0.56% | -1.27% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation | Press release | ACCESS Newswire | +0.40% | -1.60% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Reach Out | Press release | ACCESS Newswire | +0.07% | -2.33% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Stockholders to Connect | Press release | ACCESS Newswire | — | -5.12% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Shareholders to Inquire about Securities Investigation | Press release | ACCESS Newswire | -1.15% | -2.07% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | -0.06% | -0.64% | |
| HALPER SADEH LLC ENCOURAGES LIFECORE BIOMEDICAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS | Press release | PR Newswire | +2.08% | +3.08% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the LFCR section they belong to.
Where else LFCR is measured.
LFCR earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Lifecore Biomedical, Inc.'s median reaction calculated?
Every labeled LFCR news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 720 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 52% of LFCR's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does LFCR's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.